Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 1996

Reconstruction of aortic valve stenosis in the elderly. Technique and results.

Paweł Pracki, H J Kellner, Eberhard Struck

Med Sci Monit 1996; 2(1): CR62-69 :: ID: 499524

Abstract

Senile, tricuspid aortic stenosis was relieved in 26 patients (2.6%) by ultrasonic debridement in 985 aortic valve procedures between January 1990 and October 1995. There were 15 females and 11 males, aged 59 to 81 years (mean, 74). As a concomitant diagnosis, 23 patients (88%) had mostly mild, aortic valve insufficiency, 16 (61%) had coronary artery disease and 11 (42%) had mitral valve incompetence. Two operative deaths occurred and 6 patients died later. The follow-up period ranged from 16 to 73 months (mean, 29). Postoperative Doppler echocardiography showed immediately after surgery and 29 months later a decrease in peak and mean gradients across the aortic valve, three- and two-fold respectively (p<0.001). Twenty-nine months after debridement we observed a mild rise in both gradients (at peak gradient p<0.05). Directly postoperatively, the aortic valve area increased doubly and 29 months later it slightly decreased, but statistically significant in comparison with the preoperative data (p<0.001). Follow-up echocardiography demonstrated late onset of moderate aortic valve insufficiency in 6 patients and in 1 patient aortic valve restenosis required re-operation. The classification of New York Heart Association (NYHA) was improved in 13 (72%) survivors after 29 months. Only one patient showed deteriovation in his functional status. The advantage of preserving the native aortic valve in elderly patients is an argument in favour of period aortic valve reconstruction in selected patients. Longer follow-up is necessary, however, to establish this procedure as treatment of choice.

Keywords: aortic stenosis, reconstruction, Surgery, follow-up

Add Comment 0 Comments

Editorial

01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

12 Mar 2024 : Clinical Research  

Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...

Med Sci Monit In Press; DOI: 10.12659/MSM.943126  

0:00

12 Mar 2024 : Clinical Research  

Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...

Med Sci Monit In Press; DOI: 10.12659/MSM.943500  

0:00

12 Mar 2024 : Review article  

Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive Strategies

Med Sci Monit In Press; DOI: 10.12659/MSM.943240  

0:00

12 Mar 2024 : Clinical Research  

Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe Psoriasis

Med Sci Monit In Press; DOI: 10.12659/MSM.943360  

0:00

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750